Abstract Details
|
Kara A. Sands, MD
(University of Alabama at Birmingham, Department of Neurology)
PRESENTER |
Dr. Sands has nothing to disclose. |
| Karen C. Albright, DO, DO, PhD, MS, MPH (FDA) | Dr. Albright has nothing to disclose. |
| No disclosure on file | |
| Amelia K. Boehme, PhD (Columbia University) | Dr. Boehme has nothing to disclose. |
| George Howard, PhD (UAB School of Public Hlth) | Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. |
| Virginia J. Howard, PhD (University of Alabama At Birmingham) | The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH. |
| No disclosure on file | |
| Brett M. Kissela, MD, MS, FAAN (University of Cincinnati Hospital) | The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities. |
| Nita A. Limdi | No disclosure on file |
| No disclosure on file | |
| Harn Shiue, PharmD (Mayo Clinic Arizona Hospital) | Dr. Shiue has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file |